Cytonus Therapeutics is developing a cell-based platform technology focused on immuno-oncology and gene therapies for devastating and rare diseases. Cytonus’ technology leverages enucleated cells that can carry multiple therapeutic payloads, bypassing issues and side-effects associated with conventional drug delivery systems.